Company profile: HeartSine
1.1 - Company Overview
Company description
- Provider of clinically advanced automated external defibrillators for workplace, public access and home use, including samaritan PAD 350P (portable AED with simple operation and integrated battery/electrode cartridge), 360P (fully automatic with guided CPR feedback), 450P (semi-automatic with real-time CPR rate feedback and optional Wi-Fi), samaritan PAD Trainer, and HeartSine Gateway for Wi-Fi remote monitoring and management of AED readiness.
Products and services
- HeartSine samaritan PAD 360P: A fully automatic AED that delivers shocks and guided CPR feedback for lay rescuers, automating shock delivery and coaching compressions during emergency situations
- HeartSine samaritan PAD 450P: A semi-automatic AED delivering defibrillation and real-time CPR rate feedback, with optional Wi‑Fi connectivity for remote readiness monitoring of device status
- HeartSine samaritan PAD 350P: A portable AED engineered for lay rescuers, featuring simple operation and an integrated battery and electrode cartridge that streamlines maintenance and accelerates deployment in emergencies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to HeartSine
Intershunt
HQ: United States
Website
- Description: Provider of a catheter-based, minimally invasive percutaneous atrial shunt system designed to relieve left atrial pressure and improve breathing in heart failure patients; currently under development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intershunt company profile →
Endosense
HQ: Switzerland
Website
- Description: Provider of medical technology to improve the efficacy, safety and reproducibility of catheter ablation for treating cardiac arrhythmias, including TactiCath, the first and only force-sensing ablation catheter that gives physicians a real-time, objective measure of contact force; CE marked in May 2009.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endosense company profile →
Affera
HQ: United States
Website
- Description: Provider of an integrated platform for cardiac arrhythmia treatment delivering durable therapy for a wide range of patients, and pulsed field ablation for atrial fibrillation using a lattice-tip focal catheter.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Affera company profile →
Endotis
HQ: France
Website
- Description: Provider of cardiovascular therapeutics, discovering, developing, and manufacturing treatments. Also develops small-glyco drugs for thrombosis, oncology, and hematology. Portfolio includes EP217609, a neutralizable anti-coagulant for managing extracorporeal blood circulation during open-heart surgery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endotis company profile →
Sadra Medical
HQ: United States
Website
- Description: Provider of minimally invasive alternatives to traditional surgical valve replacement, developing device-based therapies to facilitate and enhance treatment of aortic valve disease and improve patient care.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sadra Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for HeartSine
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to HeartSine
2.2 - Growth funds investing in similar companies to HeartSine
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for HeartSine
4.2 - Public trading comparable groups for HeartSine
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →